Abstract program code, big data, artificial intelligence, machine learning, quantum computing.

credit: istock.com/MF3d

Simplicis named launch partner for the Beckman Coulter Life Sciences Echo Ready Digital Solutions Program

Designed to address the data challenges of acoustic dispensing, the platform captures all Echo operations within a fully digital chain of custody to improve reproducibility, traceability, and audit readiness in laboratory workflows.
| 2 min read
Written byBeckman Coulter Life Sciences
Register for free to listen to this article
Listen with Speechify
0:00
2:00

Indianapolis, 10th February 2026: Simplicis today announced that it is the launch partner for the Beckman Coulter Life Sciences Echo Ready Digital Solutions Program with the introduction of Ledger Echo Ready Platform. Echo acoustic liquid handling is widely recognized as the gold standard for contactless liquid dispensing and supports key workflows in early drug discovery as well as emerging applications in biotherapeutics engineering, synthetic biology, and nanotechnology.

The technology supports highly combinatorial workflows, miniaturization, and enables the production of high-quality assay-ready plates while reducing contamination risk associated with traditional liquid handlers. The Echo Ready partnership program aims to deliver expanded value for customers of Beckman Coulter Life Sciences and its partners by offering ready-to-execute kits and chemistries that are dispensed directly from Echo Qualified source labware as well as digital solutions that directly interface with Echo instruments.

Managing the large volumes of data that acoustic workflows generate remains a significant challenge, and manual data handling introduces risk to scientific research reproducibility. Simplicis has addressed these challenges through long-standing experience in acoustic dispensing workflows.

Since launching Ledger Acoustic in 2011, Simplicis has developed a comprehensive integration for Echo instruments and Access Workstations. With more than 15 years of experience, Simplicis delivers a data and workflow management platform designed to support complex experimental designs, including pooling, mixtures, and dynamic curve generation. Ledger Echo Ready Platform represents the next evolution of Ledger Acoustic and expands access to this capability across a broader range of users. The solution is compatible with all Echo instrument models and provides robust, reliable data management.

Validated across more than 300 workflows, the Ledger Echo Ready Platform supports sample-agnostic data integrity. All acoustic operations are captured within a fully digital chain of custody, creating a complete audit trail to support compliant efficient laboratory operations. As part of Beckman Coulter Life Sciences Echo Ready Digital Solutions Program, the Ledger Echo Ready Platform delivers a LIMS-in-a-box solution designed specifically for 026-GBL-EN-109397-v1 Echo users. The platform is commercially deployable and enables ready-to-execute workflows for Echo customers worldwide.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D molecular rendering of antibody proteins with blue and gold surface structures floating against a soft blue background
Explore the scientific advances driving more specific, potent, and adaptable antibody-based therapies.
Gloved hand holding a microcentrifuge tube while a pipette dispenses liquid
Explore how digital PCR is reshaping sterility testing to support faster, more reliable release of advanced therapy medicinal products.
Illustration of a cell undergoing division, showing two connected daughter cells with visible nuclei, rendered in blue tones
Explore how breakthroughs in fast confocal imaging and 3D cell culture converged to transform the study of complex human biology in vitro.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue